【researchmap】
https://researchmap.jp/_naowashi

<代表論文>

1. 1. Inoue H, Washida N et al. Non-tuberculous mycobacterial infections related to peritoneal dialysis, Perit Dial Int 2018;38:147-149.
2. 2. Washida N, Itoh H. Role of non-tuberculous mycobacteria in peritoneal dialysis-related infections: literature review, Contributions to Nephrology 2018 in press.
3. 3. Fujii K , Washida N et al. Multinuclear and Ground Glass-formed Cells Detected in the Peritoneal Dialysate. Clin Infect Dis 2018 in press
4. 4. Uchiyama K, Washida N et al. Consumption in Simulated Patients on Automated Peritoneal Dialysis (APD) Using a Remote Monitoring System. Clin Nephrol 2018　in press.
5. 5. Uchiyama K, Washida N et al. Determinants of Exercise Capacity and its Association with Quality of Life in Peritoneal Dialysis Patients. Perit Dial Int 2018 in press.
6. 6. Washida N, Inoue S, Kasai T, Shinozuka K, Hosoya K, Morimoto K, Wakino S, Hayashi K, Itoh H.　Impact of Switching from Darbepoetin Alpha to Epoetin Beta Pegol on Iron Utilization and Blood Pressure in CKD Patients Treated With Peritoneal Dialysis. Ther Apher Dial. 2015; 19: 450-6.   
7. 7. Wahida N, Wakino S, Tonozuka Y, Homma K, Tokuyama H, Hara Y, Hasegawa K, Minakuchi H, Fujimura K, Hosoya K, Hayashi K, Itoh H. Rho-kinase inhibition ameliorates peritoneal fibrosis and angiogenesis in a rat model of peritoneal sclerosis. Nephrol Dial Transplant 2011; 26: 2770-2779.
8. 8. Washida N, Wakino S, Hayashi K, Kuwahara T, Itoh H.Brachial-ankle pulse wave velocity predicts silent cerebrovascular diseases in patients with end-stage renal diseases. J Atheroscler Thromb 2010; 17: 165-172.